Souhaitez-vous accéder aux communiqués récents ?

$21 Million debt financing, convertible to ENLV ordinary shares at fixed $2.69175 per share, a 264% premium to the Nasdaq closing price on March 20, 2026, with a single institutional investorThe...

TAIZHOU, China, March 23, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development,...

Next‑generation facility highlights long‑standing partnership and accelerates logistics capabilities for Hasbro’s iconic global brands GREENWICH, Conn., March 19, 2026 (GLOBE NEWSWIRE) -- GXO...

GXO CEO Patrick Kelleher and KION CEO Rob Smith to discuss AI in Logistics at NVIDIA’s GTC 2026 Conference GREENWICH, Conn., & PARIS, France, March 18, 2026 (GLOBE NEWSWIRE) -- GXO Logistics,...

Sam Asher is recognized for his leadership excellence in Aerospace & Defense GREENWICH, Conn., March 17, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play...

trivago Expands Leadership Team with Three C-Level Appointments Three leaders who helped build trivago now step up to drive its next chapter, spanning tech

Torus Defence Supply Chain brings together complementary global leaders with proven capabilities and mission-critical expertise LONDON, UK, March 12, 2026 (GLOBE NEWSWIRE) -- Amentum, a global...

BioNTech erwartet ein Jahr mit zahlreichen wertrelevanten Meilensteinen (Katalysatoren) mit sechs Datenveröffentlichungen aus der späten klinischen Entwicklung, welche Immunmodulatoren,...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on...

BioNTech stärkt strategische Ausrichtung auf die wachsende spätklinische Pipeline mit Immunmodulator-, Antikörper-Wirkstoff-Konjugat- und mRNA-Kandidaten BioNTech-Mitgründer Ugur Sahin und Özlem...